Welcome to IvermectinUS official website
In the United States, ivermectin is currently approved by the Food and Drug Administration (FDA) for the treatment of certain parasitic infections in humans, such as intestinal strongyloidiasis and onchocerciasis. However, the drug has gained significant attention due to ongoing research investigating its potential antiviral properties, particularly against SARS-CoV-2, the virus responsible for COVID-19. While some studies have suggested that ivermectin may have beneficial effects in the treatment of COVID-19, the evidence remains inconclusive, and the FDA has not approved ivermectin for this indication.
Despite the lack of FDA approval for COVID-19 treatment, there have been reports of individuals attempting to self-medicate with ivermectin tablets, often obtained through unregulated sources or intended for veterinary use. This practice is highly discouraged by health authorities, as improper use or dosing of ivermectin can lead to serious adverse effects, including neurological disorders, seizures, and hepatitis. Additionally, the widespread use of ivermectin without proper oversight and monitoring can potentially contribute to the development of drug resistance, undermining its effectiveness in treating parasitic infections. To ensure the safe and appropriate use of ivermectin, it is crucial to follow the guidance of licensed healthcare professionals and await further research and regulatory evaluations before considering its use for COVID-19 or other non-approved indications.